SCHEMBL19923693

SCHEMBL19923693

CCC1(CC)C(=O)N([Si](c2ccccc2)(c2ccccc2)c2ccccc2)C(=O)N1Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.49
ELANE P08246 5/20 0.48
CTSG P08311 2/20 0.41
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
CMA1 P23946 1/20 0.41
CTRC Q99895 1/20 0.41
CYP2C19 P33261 3/20 0.41
ALDH1A1 P00352 1/20 0.39
PRTN3 P24158 1/20 0.38
KDM4E B2RXH2 2/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
MGLL Q99685 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923772 0.87 NPSR1 (0.39) NPSR1ELANECYP2C19ALDH1A1KDM4E
SCHEMBL19923529 0.86 NPSR1 (0.49) NPSR1ELANECTSGF2PLG
SCHEMBL19923621 0.86 NPSR1 (0.51) NPSR1ELANECTSGF2PLG
SCHEMBL19923606 0.84 NPSR1 (0.50) NPSR1ELANECTSGF2PLG
SCHEMBL19923557 0.83 ELANE (0.45) NPSR1ELANECTSGF2PLG
SCHEMBL19923408 0.83 NPSR1 (0.43) NPSR1ELANECTSGF2PLG
SCHEMBL19923749 0.81 NPSR1 (0.64) NPSR1ELANECTSGF2PLG
SCHEMBL19923709 0.80 NPSR1 (0.40) NPSR1ELANECYP2C19ALDH1A1LMNA
SCHEMBL19923748 0.80 NPSR1 (0.40) NPSR1ELANECYP2C19ALDH1A1LMNA
SCHEMBL19923450 0.80 ELANE (0.42) NPSR1ELANECTSGF2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN NPSR1 1322/4885ELANE 1249/4885CTSG 1654/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM NPSR1 1281/4885ELANE 1276/4885CTSG 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.